Sleep deprivation as a treatment for major depressive episodes: A systematic review and meta-analysis.
Journal article
Mitter P. et al, (2022), Sleep Med Rev, 64
Associating Violence With Schizophrenia-Risks and Biases-Reply.
Journal article
Whiting D. et al, (2022), JAMA Psychiatry
Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment.
Journal article
McKeown L. et al, (2022), J Psychopharmacol
Association between serum lithium level and incidence of COVID-19 infection.
Journal article
De Picker LJ. et al, (2022), Br J Psychiatry, 1 - 3
Mental health prior to and during the COVID-19 pandemic in individuals with bipolar disorder: Insights from prospective longitudinal data.
Journal article
Lewis KJS. et al, (2022), Bipolar Disord
Pharmacological treatment for psychotic depression.
Journal article
Kruizinga J. et al, (2021), Cochrane Database Syst Rev, 12
Use of online cultural content for mental health and well-being during COVID-19 restrictions: cross-sectional survey.
Journal article
Syed Sheriff RJ. et al, (2021), BJPsych Bull, 1 - 10
Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: systematic review, meta-analysis, and rationale
Journal article
CIPRIANI A., (2021), Molecular Psychiatry
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.
Journal article
Dean RL. et al, (2021), Cochrane Database Syst Rev, 10
Impact of COVID-19 on telepsychiatry at the service and individual patient level across two UK NHS mental health Trusts.
Journal article
Hong JS. et al, (2021), Evid Based Ment Health
The costs of bipolar disorder in the United Kingdom.
Journal article
Simon J. et al, (2021), Brain Behav
Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases.
Journal article
Taquet M. et al, (2021), EClinicalMedicine, 39
Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
Journal article
Taquet M. et al, (2021), PLoS Med, 18
Trends and variation in antidepressant prescribing in English primary care: a retrospective longitudinal study.
Journal article
Bogowicz P. et al, (2021), BJGP Open, 5
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.
Journal article
Sen A. et al, (2021), Trials, 22
Incidence and outcomes of eating disorders during the COVID-19 pandemic.
Journal article
HARRISON P. et al, (2021), British Journal of Psychiatry
Neuropsychiatric disorders and COVID-19 - Authors' reply.
Journal article
Taquet M. et al, (2021), Lancet Psychiatry, 8, 565 - 566
Learning from the global response to COVID-19 to accelerate innovation in mental health trials
Journal article
GEDDES J., (2021), World Psychiatry
A retrospective examination of care pathways in individuals with treatment-resistant depression.
Journal article
Day E. et al, (2021), BJPsych Open, 7